Feb 11, 2019 - AbbVie missed its Q4 earnings expectations, but it does have many other products to help it get back on track in the coming quarters.The big loss for the quarter was due to international sales of Humi
Feb 11, 2019 - Amgen's shares yield more than 3% and offer some of the best dividend growth metrics in the market.Over the long term, this stock's performance has crushed the broader market's.Growth appears to be sl
Feb 07, 2019 - I rank a selection of the CCC stocks and present the top 10 for consideration.Given increased market volatility, I'm focusing on defensive sectors.This month I'm ranking CCC stocks in the Health Care
Feb 05, 2019 - Roche (RHHBY) submits sBLA for Kadcyla to the FDA for adjuvant treatment of patients with HER2-positive early breast cancer with residual disease after neoadjuvant treatment.
Feb 04, 2019 - Teva (TEVA) receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP), advocating a marketing approval for its new migraine medicine, Ajovy.
Feb 04, 2019 - Pfizer's (PFE) new lung cancer medicine, Vizimpro (dacomitinib) gets recommendation from CHMP of the EMA.
Feb 01, 2019 - Roche's (RHHBY) performance in 2018 is driven by solid strength in new drugs, which more than offset competition from biosimilars.
Jan 30, 2019 - During its Q4 earnings call, Amgen (AMGN -5.2%) chief Bob Bradway said his company is maintaining its attention on potential acquisitions, large and small, that represent reasonable valuations for exp
Jan 30, 2019 - The "Fast Money" traders share their first moves for the market open.
Jan 30, 2019 - Amgen (AMGN) beats estimates for both earnings and sales in Q4. Its forecast for 2019 disappoints investors Stock dips 2.4% in after-hours trading.